DISCOUNT-OPTIONSSCHEIN - BIONTECH ADR Share Price

Certificat

DE000HC3BYA0

Market Closed - BOERSE MUENCHEN 01:16:52 24/05/2024 am IST
0.016 EUR +6.67% Intraday chart for DISCOUNT-OPTIONSSCHEIN - BIONTECH ADR
Current month+114.29%
1 month+114.29%
Date Price Change
23/24/23 0.016 +6.67%
22/24/22 0.015 +114.29%
21/24/21 0.007 0.00%
20/24/20 0.007 0.00%
17/24/17 0.007 0.00%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 01:16 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer UniCredit UniCredit
WKN HC3BYA
ISINDE000HC3BYA0
Date issued 23/01/2023
Strike 145 $
Maturity 19/06/2024 (27 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.67
Lowest since issue 0.001

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
91.47 EUR
Average target price
104.7 EUR
Spread / Average Target
+14.50%
Consensus